Part of Cleveland Clinic's Neurological Institute, the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center is a nationally recognized leader in the diagnosis and treatment of primary and metastatic spine, nerve, and brain tumors, and their effects on the nervous system. Annually, the Burkhardt Brain Tumor Center physicians record approximately 8000 patient visits and performed more than 900 surgeries.
News
- »Cleveland Clinic recognizes Brain Tumor Awareness Month
-
Approximately 300,000 people in the U.S. are diagnosed with a brain tumor each year. Although a brain tumor diagnosis can be overwhelming, there are a number of advanced treatments and surgical techniques to offer brain tumor patients hope. But like with any cancer diagnosis, early detection is key. Join our staff and patients on May 17th and 18th, from 10am - 4pm both days, in the lobby of the Taussig Cancer Center on Cleveland Clinic's main campus. We will be helping visitors learn more about brain tumor warning signs, diagnoses and treatment options. We will have informational table set up along with give-aways, educational hand-outs and raffles. We hope to see you there.
- »Cleveland Clinic Utilizes Leading-Edge Imaging Technology to Identify Hidden Brain Tumors
-
Learn how John & Mary Welsh overcame two brain tumor diagnoses and how neurosurgeon Michael Volgelbaum, MD, PhD, was able to locate and remove a hidden tumor with the help of advanced intra-operative imaging technology.
- »Dental X-Rays May Be Linked to Benign Brain Tumors
-
Glen Stevens, DO, PhD discusses the recently published study linking dental x-rays to incidents of meningiomas brain tumors.
- »Minimally Invasive Neurosurgical Techniques to Remove Brain Tumors
-
Learn more about a less-invasive brain surgery that allows for tumor removal through nose and mouth. Cleveland Clinic Pediatric Neurosurgeon, Violette Recinos, MD, comments on this new approach.
- »Cleveland Clinic offers state-of-the-art alternative to invasive brain tumor surgery
-
Cleveland Clinic’s Gamma Knife treatment combines state-of-the-art radiosurgery treatment technology with medical expertise to provide treatment solutions for the most complex brain tumor diagnoses.
- »Patients at Risk for Metastatic Brain Tumors
-
More than 1 million Americans are diagnosed with cancer every year. Approximately one-quarter of these individuals will develop metastatic brain tumors during the course of their illness. Gene Barnett, MD, Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, discusses the risks, signs/symptoms and treatment options for metastatic brain tumors.
- »New Brain Tumor Research Center of Excellence
-
The Lerner Research Institute announces the new Brain Tumor Research Center of Excellence. Under the leadership of Steven Rosenfeld, MD, PhD, the mission of this first Center of Excellence in cancer research is to “translate” scientific findings into diagnostic and therapeutic interventions to improve the lives of patients afflicted with brain tumors.
- »Cleveland Clinic test new therapy for brain tumors
-
Cleveland Clinic is now offering patients a clinical trial that to a retroviral gene therapy -- developed by Tocagen, a California-based biopharmaceutical company. This trial is currently being tested for use in patients with recurrent high-grade glioblastomas.
- »Parma Heights family ties help overcome adversity
-
When John Tondich started having painful headaches while wrestling as a sophomore at Trinity High School in February, his mother and father were concerned.
Joe Tondich knew his son was in serious pain because John had always been a tough kid and was not what he would call a complainer.
Being a mother, Debbie worried more than Joe.
When doctors found a cancerous mass on John’s brain, he was rushed by ambulance to the Cleveland Clinic’s Brain Tumor and Neuro-Oncology Center. Dr. Violette Recinos, a surgeon at the hospital, assured the Tondich family that the tumor was in the best place to have a tumor, which made the operation to remove the tumor a relatively “easy” one.
